How do we get better outcome with botulinum toxin in the treatment of children with spastic hemiplegia?
Dai
A I
AI
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002648:Child; D004359:Drug Therapy, Combination; D006429:Hemiplegia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009128:Muscle Spasticity / Q000150:complications / Q000188:drug therapy; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D010276:Parasympatholytics / Q000008:administration & dosage; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D010276:Parasympatholytics; D019274:Botulinum Toxins, Type A